ArticlePloS one2017

Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis.

Surbhi Sidana et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.